Synthesis of amide and sulfonamide substituted N-aryl 6-aminoquinoxalines as PFKFB3 inhibitors with improved physicochemical propertiesNicolas Boutard, Charles‐Henry Fabritius, Anna Cierpich et al.|Bioorganic & Medicinal Chemistry Letters|2018Cited by 24
Discovery and Structure–Activity Relationships of <i>N</i>‐Aryl 6‐Aminoquinoxalines as Potent PFKFB3 Kinase InhibitorsNicolas Boutard, Charles‐Henry Fabritius, Arkadiusz Białas et al.|ChemMedChem|2018Cited by 22
5-Keto-3-cyano-2,4-diaminothiophenes as selective maternal embryonic leucine zipper kinase inhibitorsNicolas Boutard, Piotr Kowalczyk, Aleksandra Sabiniarz et al.|Bioorganic & Medicinal Chemistry Letters|2018Cited by 8
Abstract 696: Development of selective CDK8 inhibitors for colorectal cancer and mantle cell lymphoma treatment.Tomasz Rzymski, Krzysztof Brzózka, Adrian Zarębski et al.|Cancer Research|2013Cited by 0
Abstract 2160: Development of selective MELK kinase inhibitors for cancer treatments.Piotr Kowalczyk, Krzysztof Brzózka, Paulina Węgrzyn et al.|Cancer Research|2013Cited by 0